Bacillus Coagulans, a powerful probiotic bacterium, has gained attention for its potential in combating Candida overgrowth. Candida, a type of yeast, is normally present in small quantities in the human body. However, factors such as a weakened immune system, antibiotic use, or hormonal imbalances can lead to Candida overgrowth, resulting in various health issues. Bacillus coagulans has shown promising abilities to counteract Candida overgrowth and promote a healthy microbial balance.

One key mechanism by which Bacillus Coagulans fights Candida is through competitive exclusion. Bacillus coagulans colonizes the gut, creating an environment that makes it difficult for Candida to thrive. It produces antimicrobial substances that inhibit Candida growth and prevents its adherence to the intestinal walls.

Moreover, Bacillus coagulans supports the immune system's defense against Candida. It stimulates the production of immune cells and enhances the activity of natural killer cells, which are crucial in eliminating Candida and maintaining a healthy microbiome.

Clinical studies have shown positive results in using Bacillus coagulans as a complementary approach to combat Candida overgrowth. It has been observed to reduce Candida-related symptoms such as bloating, gas, and recurrent infections.

 

Read more http://thrillfillerblog.weebly.com/article/bacillus-coagulans-a-natural-weapon-against-antibiotic-associated-diarrhea

https://www.coherentmarketinsights.com/press-release/global-bacillus-coagulans-market-to-surpass-us-819-million-by-2025-1120